Dual Target HIV-1 Assay

Rapidly mutating HIV-1 virus can continue to evade quantification with a single target viral load assay.

The innovative dual target HIV-1 assay from Roche Molecular Diagnostics measures two unique regions of the HIV-1 genome, which are not subject to selective drug pressure. Therefore drug-induced mutations should not impact the assay’s ability to detect and quantify the virus accurately.

In turn, more accurate results drive better decisions for a positive impact on patients’ lives.

playicon

Roche Dual Target HIV 1

playicon

videoCtrl

/

fullScreen

Update Required
To play the media you will need to either update your browser to a recent version or update your
Flash plugin.

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.